Timber Pharmaceuticals Profit Margin

The latest profit margin for TMBR is -180.91% as of June 2023. That compares with -440.14% in the prior-year period — up 58.9% year over year. That is below the Healthcare sector average of 15.58%. Investors often review this figure alongside Timber Pharmaceuticals's historical trend and sector peers before judging valuation or financial health.

Over the past year, TMBR's profit margin moved from -440.14% to -180.91% — a 58.9% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Timber Pharmaceuticals's valuation or profitability profile.

Against Healthcare companies, TMBR currently prints -180.91% for profit margin, while the sector average sits near 15.58%. That is roughly 116185.1% below the sector mean. Large gaps often invite a closer look at Timber Pharmaceuticals's growth, margins, and balance sheet.

Profit Margin shows how effectively Timber Pharmaceuticals converts resources into returns. At -180.91%, TMBR may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -440.14% in the prior-year period — up 58.9% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting TMBR's profit margin (-180.91%), review year-over-year change from -440.14%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.